new_adrs_0322_1234|FUSN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_1234|FUSN|1|Fusion Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Fusion Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Fusion Pharmaceuticals Inc Inventories (Quarterly) (USD)|Fusion Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Fusion Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Fusion Pharmaceuticals Inc Book Value (Quarterly) (USD)|Fusion Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Fusion Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Fusion Pharmaceuticals Inc EV to Revenues|Fusion Pharmaceuticals Inc EV to Earnings|Fusion Pharmaceuticals Inc EV to Free Cash Flow|Fusion Pharmaceuticals Inc EV to Assets (Quarterly)|Fusion Pharmaceuticals Inc PS Ratio|Fusion Pharmaceuticals Inc PE Ratio|Fusion Pharmaceuticals Inc Price to Book Value|Fusion Pharmaceuticals Inc PEG Ratio|Fusion Pharmaceuticals Inc Debt to Equity Ratio|Fusion Pharmaceuticals Inc Dividend Yield|Fusion Pharmaceuticals Inc Shareholder Yield (TTM)|Fusion Pharmaceuticals Inc Percent of Shares Outstanding Short|Fusion Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Fusion Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Fusion Pharmaceuticals Inc Return on Invested Capital|Fusion Pharmaceuticals Inc Quality Ratio Score|Fusion Pharmaceuticals Inc Momentum Score|Fusion Pharmaceuticals Inc Beta (1Y)|Fusion Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Fusion Pharmaceuticals Inc Institutional Investor Ownership Percentage|Fusion Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Fusion Pharmaceuticals Inc Total Employees (Annual)|Fusion Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Fusion Pharmaceuticals Inc Shares Outstanding|Fusion Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Fusion Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Fusion Pharmaceuticals Inc Payout Ratio|Fusion Pharmaceuticals Inc Quick Ratio (Quarterly)|Fusion Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Fusion Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Fusion Pharmaceuticals Inc Effective Tax Rate (TTM)|Fusion Pharmaceuticals Inc Return on Equity|Fusion Pharmaceuticals Inc Net Income (TTM) (USD)|Fusion Pharmaceuticals Inc Revenue (TTM) (USD)|Fusion Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Fusion Pharmaceuticals Inc Revenue (Quarterly) (USD)|Fusion Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Fusion Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Fusion Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Fusion Pharmaceuticals Inc Net Income (Quarterly) (USD)|Fusion Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Fusion Pharmaceuticals Inc Price (USD)|Fusion Pharmaceuticals Inc Total Return Price (USD)|Fusion Pharmaceuticals Inc Enterprise Value (USD)|Fusion Pharmaceuticals Inc 30-Day Average Daily Volume|Fusion Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_adrs_0322_1234|FUSN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_1234|FUSN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_adrs_0322_1234|FUSN|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||||1.44827586207|92|||1.44827586207||92|1.44827586207||15.2|91.2857142857|91.2857142857|91.2857142857|||30.2857142857|30.375||29.5|91.4|275|91.4|31.125||91.2857142857||92|91.4|91.4444444444|91.2857142857||91.2857142857|||92||91.4|91.4|91.4|91.4|1.44827586207|1.44827586207|1.44827586207|1.44827586207|1.43715846995||
new_adrs_0322_1234|FUSN|6|7|7||7||7|7|7||7|7||||435|1|||435||1|435||40|7|7|7|||7|8||2|10|1|10|16||7||1|10|9|7||7|||1||10|10|10|10|435|435|435|406|183||
new_adrs_0322_1234|FUSN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_1234|FUSN|201903||||||||||||||||||||||||||||||||||21.3033||-0.1846||||||-0.1846|||||||||1.171|-3.919|-3.933||||||||
new_adrs_0322_1234|FUSN|201906||||||||||||||||||||||||||||||||||21.3033||-0.1622||||||-0.1622|||||||||1.771|-3.438|-3.456|0.148|||||||
new_adrs_0322_1234|FUSN|201909||||||||||||||||||||||||||||||||||21.3033||-0.0279||||||-0.0279|||||||||1.922|-0.413|-0.594|0.247|||||||
new_adrs_0322_1234|FUSN|201912|66.553|65.344||1.272||102.888|4.273|98.615||-33.488|-34.774||||||||||||||0.49|0.947||||||||21.3033||-0.3852|||41.664|||-0.3852||-1.5749||-16.189|||||2.724|-8.168|-8.206|0.181|||||||
new_adrs_0322_1234|FUSN|202003|68.74|67.417||1.334||15.052|6.795|8.257||58.337|-45.092||||||||||||||0.693|3.068||||||||41.664|40|-0.2785|||41.664|||-0.2395||-1.3481||-22.478|||||4.327|-10.16|-10.222|0.147|||||||
new_adrs_0322_1234|FUSN|202006|320.132|318.892||1.403||7.903|7.61|0.293||315.207|-89.825||||-19.1424||||2.3092|||||0.5998|0.411|0.981||||||||2.3662||-18.91|41.664||41.664|||-17.0261|-197.625|-0.6806||-63.755|||||3.988|-44.583|-44.733|0.022|17.47|17.47|408.9781|94275.7||13.76|12.87
new_adrs_0322_1234|FUSN|202009|296.884|291.952||1.981||5.605|5.309|0.296||306.454|-99.818||||-6.6035||||1.6357|||||0.648|0.891|0.956||||||||41.6828||-0.24|41.7024||41.7024|||-0.24||-0.0889||-73.154|||||5.79|-10.178|-9.993|0.08|12.02|12.02|209.3108|30533.8667||12.4|13.51
new_adrs_0322_1234|FUSN|202012|228.164|222.399||1.967||16.163|11.857|4.306||294.513|-113.203||||-8.672||||1.6647|||||0.9793|0.794|6.198||||||||41.7258|61|-0.32|41.7258||41.7258|||-0.32||-3.4481||-78.333|||||6.639|-10.801|-13.385|0.078|11.75|11.75|267.8792|63955.9||11.3|11.68
new_adrs_0322_1234|FUSN|202103|233.855|227.22||10.06||18.237|7.618|10.619||279.071|-130.732||||-5.0041||||1.6074|||||0.8572|0.979|1.234||||||||41.7843||-0.42|41.8452||41.8452|||-0.42||-3.059||-85.64|||||6.964|-17.536|-17.529|0.096|10.72|10.72|221.3605|51390.0667||8.6|8.21
new_adrs_0322_1234|FUSN|202106|185.156|178.519||9.883||18.605|9.365|9.24||263.551|-157.585||||-2.9946|0.5878|||1.3067|||||0.4296|1.351|0.685||||1|-0.1506|||42.5013||-0.63|42.6211||42.6211||19.2066|-0.63||-3.6815||-67.76|||0.521||6.642|-26.839|-26.853|0.097|8.08|8.08|165.8595|112049.3|-53.7493|8.15|9.33
new_adrs_0322_1234|FUSN|202109|203.009|192.617||9.406||21.808|13.563|8.245||246.495|-177.014||||-2.3378|0.5534|||1.3837|||||0.2811|2.285|3.803||||2|0.5683|||43.0228||-0.45|43.0662||43.0662||14.3701|-0.45||-3.5396||-77.196|||0.325||7.156|-19.381|-19.429|0.107|7.92|7.92|148.4673|51968.5|-34.1098|7.01|5.8
new_adrs_0322_1234|FUSN|202112|||||||||||||||0.2052||||0.7286|||||0.2664||||||2|-0.1372||96.4735||||||||||||||||||||||4.17|4.17|-13.0309|30420.7|-64.5106|7.5|7.53
new_adrs_0322_1234|FUSN|202203|||||||||||||||-1.9512||||1.2842||||||||||||||||||||||||||||||||||||7.35|7.35|123.9196|57454.2333|-35.0133||